Once again we will be attending the premier event for education, science, research and networking in nuclear medicine and molecular imaging – SNMMI 2023 – you will find us in Chicago, Illinois, June 24-27, Booth #3082.

We have been an almost annual attendee of this major conference since 2003 and are now looking forward to our 17th participation. This year we will be represented by our General Manager Dr. Andreas Kluge and Managing Director Andreas Fintelmann, who will provide expert advice on Phase I-III clinical trials as well as our various services and CRO capabilities . We will also have ABX-CRO INC.’s Chief Executive Officer Moritz Kallerhoff and Senior Project Manager Dr. Konstantinos Kakos.

Stop by and chat with us about how ABX-CRO can support you in conducting your clinical trial!

Untitled Document